We observed that patients with advanced fibrosis did not present a higher intake of SFA compared to patients without advanced fibrosis, which suggests that the palmitic acid increase found in RBC reflects increased de novo lipogenesis (DNL), in addition to reduced ELOVL6 activity. Here, ELOVL6 is linked to fibrosis.